ROBERT BRADWAY
Chairman & Chief Executive Amgen Inc.
Bradway joined biotech giant Amgen in 2006, becoming chief executive in 2012 and chairman a year later. During his tenure as chief executive, revenue has grown 50% to nearly $26 billion last year, while market cap shot up 107% to $135 billion as of mid-April. In recent years, Bradway has honed Amgen’s focus more on drugs to treat cancers as well as cardiovascular and inflammatory diseases. Prior to joining Amgen, Bradway spent 20 years at Morgan Stanley, rising through the ranks to become managing director at the finance firm’s London office. Bradway is also a director of Boeing Co. and chairs its finance committee.
2022 LA500 | HEALTH CARE
en-us
2022-06-20T07:00:00.0000000Z
2022-06-20T07:00:00.0000000Z
https://labusinessjournal.pressreader.com/article/283046943143178
LABJ